Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reolysin in Metastatic Sarcoma
NCT00503295Phase 2Completed
- Sponsor
- Oncolytics Biotech Inc.
- Start
- Jun 2007
- Primary completion
- Feb 2011
- Modality
- Oncolytic Viruses, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pelareorep in bone sarcoma, soft tissue sarcoma (STS), sponsored by Oncolytics Biotech Inc.. Started Jun 2007; status: completed.
02
Drugs
pelareorep
03
Conditions
bone sarcomasoft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00503295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00503295.